106190.KQ High Tech Pharm Co. Ltd

Healthcare Oil, Gas & Consumable Fuels KOSDAQ
8,650 KRW
Close of Oct 31, 2026
8,400 25,000
Market cap
KRW 92.0B
P/E
7.8x
P/B
0.69x
ROE
7.4%
Dividend yield
1.16%
Fundamental score
2.5/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 106190.KQ undervalued?

Graham number
Price8,650
Graham value17,686
Discount51.1%

106190.KQ trades 51.1% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

High Tech Pharm Co. Ltd fundamental analysis

14 of 22 checks passed

ROE 0/2

Low return on equity (7.4%), below 10%.

ROA 1/1

Return on assets (6.7%) is above the industry median (1.4%).

Profit Consistency 1/2

Profitable for 4 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-16.3%) is below the industry median (1.8%).

Revenue Growth 0/2

Revenue shrank 12.0% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 11,163.8x against interest expense, well covered.

PE vs Market 1/1

PE (7.8x) is below the market median (11.3x).

PE vs Industry 1/1

PE (7.8x) is below the industry median (11.4x).

PBV 1/1

Price to book (0.7x) is below the industry median (0.9x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 5.4, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (1.2%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 7 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 9.3%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

High Tech Pharm Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About High Tech Pharm Co. Ltd

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.

Full company profile